Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Project Description:
Datamonitors' China-Biotics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by China-Biotics, Inc. since January 2007.
Scope:
– Provides intelligence on China-Biotics, Inc.'s M&A, strategic partnerships and alliances, capital raising and private equity transactions. – Detailed reports of various financial transactions undertaken by China-Biotics, Inc. and its subsidiaries since 2007. – Information about key financial and legal advisors for China-Biotics, Inc.'s financial deals transactions. – Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
Highlights:
This report includes China-Biotics, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by China-Biotics, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Reasons to Purchase:
– Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances. – Form an independent opinion about China-Biotics, Inc.’s growth strategies through the organic and inorganic activities undertaken since 2007. – Track your competitors’ business structure and growth strategies.
Our reports have been used by over 10K customers, including:
186 pages •
By Global Industry Analysts
• Mar 2021
Project Details:
- StrategyR - A Trademark of Global Industry Analysts, Inc.
- Project Edition: 9
- Influencer Pool: 948
- MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies....
The protective cultures market is projected to grow at a CAGR of 4.9%; the key drivers include growth in the edible oils industry, increase in demand for higher nutritional value in edible oils, and the technological developments to overcome process limitations. The protective cultures market is estimated at USD 101 million in 2018...
36 pages •
By Euromonitor International
• Aug 2018
The health and wellness foods industry is experiencing growth ahead of regular packaged food, driven by changing consumer preferences towards a more natural offering, aiming to adopt a more holistic approach to a healthy diet. This has resulted in rapid shifts in the category/brand portfolios of key manufactures, as well as growing innovation...
This study covers the latent demand outlook for fiber and probiotic health foods across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter...
Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: Datamonitors' SCOLR Pharma,...
Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: Datamonitors' Industrial...
Summary Indena SpA (Indena) is a provider of active ingredients. It identifies, develops and manufactures active principles derived from plants which find applications in pharmaceutical, health-food and personal care industries. It produces standardized extracts from plants, which are recognized to have therapeutic properties,...
Pharmaceutical
Nutraceutical
APAC
Europe
North America
India
China
Japan
Middle East
United States
Italy
France
Karnataka
Africa
Brazil
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.